Back to List

Use Of Itolizumab On Moderate To Severe COVID-19 Patients

Posted by Devendra Kumar
11
Jul 14, 2020
27 Views
Biotech major Biocon has announced that it is launching a new biological drug Itolizumab to treat moderate to severe cases of COVID-19. The company received approval from the Drug Controllers General of India to market the injection for emergency use in India for treatment of cytokine release syndrome in moderate/severe cases of ARDS caused due to coronavirus.
Comments
avatar
To join the discussion, simply log in with your Google or Facebook account.

How it works:

  1. Click one of the login buttons above
  2. You'll be redirected to the authorization page
  3. After logging in, you'll be returned to the forum
  4. Your guest account will be automatically created if it's your first time

© APSense LTD. All-in-One Business Hub. All Rights Reserved. This forum service is provided by APSense.com